|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | A61K 48/00 | (2006.01) |
| C12N 15/861 | (2006.01) |
| (11) | Patento numeris | 3191139 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15825383.1 |
| Europos patento paraiškos padavimo data | 2015-07-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-07-19 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-10-07 |
| (46) | Apibrėžties vertimo paskelbimo data | 2021-01-25 |
| (86) | Numeris | PCT/US2015/040866 |
| Data | 2015-07-17 |
| (87) | Numeris | WO 2016/014353 |
| Data | 2016-01-28 |
| (30) | Numeris | Data | Šalis |
| 201462028638 P | 2014-07-24 | US |
| (72) |
SANDBERG, Michael A., US
PAWLYK, Basil, US
LI, Tiansen, US
SHU, Xinhua, GB
WRIGHT, Alan Finlay, GB
ALI, Robin, US
|
| (73) |
Massachusetts Eye & Ear Infirmary,
243 Charles Street, Boston, MA 02114,
US
UCL Business Ltd, The Network Building 97 Tottenham Court Road, London W1T 4TP, GB The Government of the United States of America as represented by the Secretary, Department of Health and Human Service, The Office of Technology Transfer National Institutes of Health 6011 Executive Boulevard Suite 325, MSC 7660, Bethesda, MD 20892-7660, US |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Pigmentiniam retinitui skirta RPGR genų terapija |
| RPGR GENE THERAPY FOR RETINITIS PIGMENTOSA |
| Mokėjimo data | Galiojimo metai | Suma | |
| 2025-07-01 | 11 | 289.00 EUR |
| 2026-07-17 |